GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Institutional Ownership

InNexus Biotechnology (InNexus Biotechnology) Institutional Ownership : 0.18% (As of Jun. 22, 2024)


View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, InNexus Biotechnology's institutional ownership is 0.18%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, InNexus Biotechnology's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, InNexus Biotechnology's Float Percentage Of Total Shares Outstanding is 0.00%.


InNexus Biotechnology Institutional Ownership Historical Data

The historical data trend for InNexus Biotechnology's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Institutional Ownership Chart

InNexus Biotechnology Historical Data

The historical data trend for InNexus Biotechnology can be seen below:

2007-11-30 2007-12-31 2008-01-31 2008-02-29 2008-03-31 2008-04-30 2008-05-31 2008-06-30 2008-07-31 2008-08-31
Institutional Ownership 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.18 0.18 0.18

InNexus Biotechnology Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


InNexus Biotechnology (InNexus Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines